PMID: 80011Jul 1, 1978Paper

Repeating covalent structure of streptococcal M protein

Proceedings of the National Academy of Sciences of the United States of America
E H BeacheyA H Kang

Abstract

We have attempted to identify the covalent structure of the M protein molecule of group A streptococci that is responsible for inducing type-specific, protective immunity. M protein was extracted from type 24 streptococci, purified, and cleaved with cyanogen bromide. Seven cyanogen bromide peptides were purified and further characterized. Together, the peptides account for the entire amino acid content of the M protein molecule. Each of the purified peptides possessed the type-specific determinant that inhibits opsonic antibodies for group A streptococci. The primary structures of the amino-terminal regions of each of the purified peptides was studied by automated Edman degradation. The partial sequences of two of the peptides were found to be identical to each other and to that of the uncleaved M protein molecule through at least the first 27 residues. The amino-terminal sequences of the remaining five peptides were identical to each other through the twentieth residue but completely different from the amino-terminal region of the other two peptides. However, the type-specific immunoreactivity and the incomplete analysis of the primary structure of the seven peptides suggest that the antiphagocytic determinant resides in a rep...Continue Reading

References

Oct 1, 1973·The Journal of Clinical Investigation·E H Beachey, G H Stollerman
Dec 19, 1973·Biochemical and Biophysical Research Communications·C L ZimmermanE Appella
Aug 1, 1971·The Journal of Experimental Medicine·E H Beachey, G H Stollerman
Oct 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·E N Fox, M K Wittner
Jan 1, 1967·Proceedings of the Society for Experimental Biology and Medicine·C G Becker
Mar 1, 1967·European Journal of Biochemistry·P Edman, G Begg
Jul 1, 1952·The Journal of Experimental Medicine·R C LANCEFIELD, G E PERLMANN

❮ Previous
Next ❯

Citations

Oct 1, 1987·Molecular & General Genetics : MGG·P HeinrichF Götz
Jan 1, 1984·The International Journal of Biochemistry·U MatsukuraH Kato
Jul 29, 1983·Journal of Immunological Methods·R ArnonC O Jacob
Jan 1, 1976·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·B A Margulis, G P Pinaev
Aug 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·B HoseinV A Fischetti
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B N ManjulaV A Fischetti
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·E H BeacheyL Chedid
Jan 1, 1985·The Journal of Experimental Medicine·J B Dale, E H Beachey
Jun 1, 1985·The Journal of Experimental Medicine·V A FischettiJ R Scott
Aug 1, 1985·The Journal of Experimental Medicine·J B Dale, E H Beachey
May 1, 1986·The Journal of Experimental Medicine·J B Dale, E H Beachey
Nov 1, 1986·The Journal of Experimental Medicine·J B Dale, E H Beachey
Jul 25, 2000·Clinical Microbiology Reviews·M W Cunningham
Jun 16, 1982·Biochimica Et Biophysica Acta·T Hatahara, J M Seyer
Mar 1, 1988·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·O KühnemundW Köhler
Jan 29, 1980·Biochemical and Biophysical Research Communications·J M SeyerE H Beachey
May 1, 1980·The American Journal of Medicine·G H Stollerman
Dec 1, 1980·Acta Pathologica Et Microbiologica Scandinavica. Section B, Microbiology·I EliassonP Christensen
Nov 1, 1979·Hospital Practice·E H BeacheyA L Bisno
Jul 1, 1989·Clinical Microbiology Reviews·V A Fischetti
Oct 1, 1987·Infection and Immunity·P Goroncy-BermesW Opferkuch
Mar 1, 1990·Infection and Immunity·J B DaleD Schifferli
Apr 1, 1981·Infection and Immunity·I van de Rijn, V A Fischetti
Mar 1, 1980·Infection and Immunity·A M El KholyL Wannamaker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.